Extrastriatal dopaminergic abnormalities of DA homeostasis in Parkinson's patients with medication-induced pathological gambling: A [11C] FLB-457 and PET study
暂无分享,去创建一个
Ji Hyun Ko | Antonio P. Strafella | Sylvain Houle | Nicola J. Ray | Anthony E. Lang | Sang Soo Cho | Giovanna Pellecchia | S. Houle | A. Strafella | A. Lang | S. Cho | G. Pellecchia | J. Ko | J. Miyasaki | F. Antonelli | M. Zurowski | Francesca Antonelli | Janis M. Miyasaki | Mateusz Zurowski
[1] Y. Kang,et al. Regulation of dopaminergic neuron firing by heterogeneous dopamine autoreceptors in the substantia nigra pars compacta , 2011, Journal of neurochemistry.
[2] A. Lang,et al. Prevalence of repetitive and reward-seeking behaviors in Parkinson disease , 2006, Neurology.
[3] S. Houle,et al. Drug-induced deactivation of inhibitory networks predicts pathological gambling in PD , 2010, Neurology.
[4] R. Roth,et al. Evidence for the absence of impulse-regulating somatodendritic and synthesis-modulating nerve terminal autoreceptors on subpopulations of mesocortical dopamine neurons , 1984, Neuroscience.
[5] M. Hallett,et al. Mechanisms Underlying Dopamine-Mediated Reward Bias in Compulsive Behaviors , 2010, Neuron.
[6] Mitul A Mehta,et al. DAT1 and COMT Effects on Delay Discounting and Trait Impulsivity in Male Adolescents with Attention Deficit/Hyperactivity Disorder and Healthy Controls , 2010, Neuropsychopharmacology.
[7] A. Strafella,et al. Dopamine Agonists Diminish Value Sensitivity of the Orbitofrontal Cortex: A Trigger for Pathological Gambling in Parkinson's Disease? , 2009, Neuropsychopharmacology.
[8] J. Fallon. Topographic Organization of Ascending Dopaminergic Projections a , 1988, Annals of the New York Academy of Sciences.
[9] D. Durstewitz,et al. The ability of the mesocortical dopamine system to operate in distinct temporal modes , 2007, Psychopharmacology.
[10] D. Zald,et al. Dopaminergic Network Differences in Human Impulsivity , 2010, Science.
[11] A. Lang,et al. Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients. , 2010, Archives of neurology.
[12] Christer Halldin,et al. A PET-study of [11C]FLB 457 binding to extrastriatal D2-dopamine receptors in healthy subjects and antipsychotic drug-treated patients , 1997, Psychopharmacology.
[13] R. Wise. Roles for nigrostriatal—not just mesocorticolimbic—dopamine in reward and addiction , 2009, Trends in Neurosciences.
[14] Michael J. Frank,et al. Hold Your Horses: Impulsivity, Deep Brain Stimulation, and Medication in Parkinsonism , 2007, Science.
[15] D. Collins,et al. Automatic 3D Intersubject Registration of MR Volumetric Data in Standardized Talairach Space , 1994, Journal of computer assisted tomography.
[16] Thomas J. H. Chen,et al. Manipulation of catechol-O-methyl-transferase (COMT) activity to influence the attenuation of substance seeking behavior, a subtype of Reward Deficiency Syndrome (RDS), is dependent upon gene polymorphisms: a hypothesis. , 2007, Medical hypotheses.
[17] V. B. Domesick. Neuroanatomical Organization of Dopamine Neurons in the Ventral Tegmental Area a , 1988, Annals of the New York Academy of Sciences.
[18] L. Tremblay,et al. Non-motor dopamine withdrawal syndrome after surgery for Parkinson's disease: predictors and underlying mesolimbic denervation. , 2010, Brain : a journal of neurology.
[19] Dardo Tomasi,et al. Addiction circuitry in the human brain. , 2012, Annual review of pharmacology and toxicology.
[20] J. Javitch,et al. D2 Receptors Regulate Dopamine Transporter Function via an Extracellular Signal-Regulated Kinases 1 and 2-Dependent and Phosphoinositide 3 Kinase-Independent Mechanism , 2007, Molecular Pharmacology.
[21] A. Lammertsma,et al. Simplified Reference Tissue Model for PET Receptor Studies , 1996, NeuroImage.
[22] P. Blier,et al. Sustained Administration of Pramipexole Modifies the Spontaneous Firing of Dopamine, Norepinephrine, and Serotonin Neurons in the Rat Brain , 2009, Neuropsychopharmacology.
[23] Antonieta Lavin,et al. Mechanisms Underlying Differential D1 versus D2 Dopamine Receptor Regulation of Inhibition in Prefrontal Cortex , 2004, The Journal of Neuroscience.
[24] M. Zack,et al. Parallel roles for dopamine in pathological gambling and psychostimulant addiction. , 2009, Current drug abuse reviews.
[25] P S Goldman-Rakic,et al. Prominence of the dopamine D2 short isoform in dopaminergic pathways. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[26] I. Lucki,et al. Effects of chronic treatment with selective agonists on the subtypes of dopamine receptors , 1992, Brain Research.
[27] V Kaasinen,et al. Extrastriatal dopamine D2 and D3 receptors in early and advanced Parkinson’s disease , 2000, Neurology.
[28] Valerie Voon,et al. Parkinson disease: Impulsive choice—Parkinson disease and dopaminergic therapy , 2011, Nature Reviews Neurology.
[29] M. Potenza,et al. Similarities and differences between pathological gambling and substance use disorders: a focus on impulsivity and compulsivity , 2011, Psychopharmacology.
[30] Mark Hallett,et al. Impulse control disorders in Parkinson's disease: recent advances. , 2011, Current opinion in neurology.
[31] E. Hollander,et al. The Gambling Symptom Assessment Scale (G-SAS): A reliability and validity study , 2009, Psychiatry Research.
[32] T. Robbins,et al. l-Dopa medication remediates cognitive inflexibility, but increases impulsivity in patients with Parkinson’s disease , 2003, Neuropsychologia.
[33] J. Patton,et al. Factor structure of the Barratt impulsiveness scale. , 1995, Journal of clinical psychology.
[34] A. Benabid,et al. Role of dopaminergic treatment in dopamine receptor down-regulation in advanced Parkinson disease: a positron emission tomographic study. , 2004, Archives of neurology.
[35] S. Houle,et al. Increased striatal dopamine release in Parkinsonian patients with pathological gambling: a [11C] raclopride PET study. , 2009, Brain : a journal of neurology.
[36] J. Mazziotta,et al. MRI‐PET Registration with Automated Algorithm , 1993, Journal of computer assisted tomography.
[37] J. Seamans,et al. The principal features and mechanisms of dopamine modulation in the prefrontal cortex , 2004, Progress in Neurobiology.
[38] R. Passingham,et al. Serotonin and Dopamine Play Complementary Roles in Gambling to Recover Losses , 2011, Neuropsychopharmacology.
[39] P. Jenner,et al. Pharmacology of dopamine agonists in the treatment of Parkinson’s disease , 2002, Neurology.
[40] Dimitris Samaras,et al. Oral methylphenidate normalizes cingulate activity in cocaine addiction during a salient cognitive task , 2010, Proceedings of the National Academy of Sciences.
[41] C. Halldin,et al. Quantification of [11C]FLB 457 Binding to Extrastriatal Dopamine Receptors in the Human Brain , 1999, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[42] R. Narendran,et al. Positron emission tomography imaging of amphetamine‐induced dopamine release in the human cortex: A comparative evaluation of the high affinity dopamine D2/3 radiotracers [11C]FLB 457 and [11C]fallypride , 2009, Synapse.
[43] M. Santiago,et al. The regulation of dopamine release from nigrostriatal neurons in conscious rats: the role of somatodendritic autoreceptors. , 1991, European journal of pharmacology.
[44] Mary L. Schneider,et al. High-Affinity Dopamine D2/D3 PET Radioligands 18F-Fallypride and 11C-FLB457: A Comparison of Kinetics in Extrastriatal Regions Using a Multiple-Injection Protocol , 2010, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[45] M. Potenza,et al. The neurobiology of pathological gambling and drug addiction: an overview and new findings , 2008, Philosophical Transactions of the Royal Society B: Biological Sciences.
[46] Nicola J. Ray,et al. Dopamine, Reward, and Frontostriatal Circuitry in Impulse Control Disorders in Parkinson's Disease: Insights from Functional Imaging , 2010, Clinical EEG and neuroscience.
[47] M. Hallett,et al. Dopamine agonists and risk: impulse control disorders in Parkinson's disease. , 2011, Brain : a journal of neurology.
[48] A. Verma. Prevalence of repetitive and rewardseeking behaviors in Parkinson disease , 2007 .
[49] Robert Vlietinck,et al. The Catechol-O-Methyl Transferase Val158Met Polymorphism and Experience of Reward in the Flow of Daily Life , 2008, Neuropsychopharmacology.
[50] J. Cummings,et al. The Montreal Cognitive Assessment, MoCA: A Brief Screening Tool For Mild Cognitive Impairment , 2005, Journal of the American Geriatrics Society.
[51] K Suzuki,et al. Reproducibility of [11C]FLB 457 binding in extrastriatal regions , 2001, Nuclear medicine communications.
[52] N. Volkow,et al. Addiction: Beyond dopamine reward circuitry , 2011, Proceedings of the National Academy of Sciences.
[53] G. Di Chiara,et al. 6-Hydroxydopamine lesions reduce specific [3H]sulpiride binding in the rat substantia nigra: direct evidence for the existence of nigral D-2 autoreceptors. , 1987, European journal of pharmacology.
[54] Vincent J. Cunningham,et al. Parametric Imaging of Ligand-Receptor Binding in PET Using a Simplified Reference Region Model , 1997, NeuroImage.
[55] A. Lang,et al. Impulse control disorders in parkinson disease: A multicenter case–control study , 2011, Annals of neurology.
[56] Fang Liu,et al. Dopamine transporter cell surface localization facilitated by a direct interaction with the dopamine D2 receptor , 2007, The EMBO journal.
[57] C. Clarke,et al. Systematic review of levodopa dose equivalency reporting in Parkinson's disease , 2010, Movement disorders : official journal of the Movement Disorder Society.
[58] A. Strafella,et al. Reduced dopamine transporter density in the ventral striatum of patients with Parkinson's disease and pathological gambling , 2010, Neurobiology of Disease.
[59] R. Kessler,et al. Analysis of emission tomographic scan data: limitations imposed by resolution and background. , 1984, Journal of computer assisted tomography.
[60] Lars Farde,et al. Measurement of Methylphenidate-Induced Change in Extrastriatal Dopamine Concentration using [11C]FLB 457 PET , 2007, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[61] N. Volkow,et al. Dysfunction of the prefrontal cortex in addiction: neuroimaging findings and clinical implications , 2011, Nature Reviews Neuroscience.